Navigation Links
DrugNews Update: Merck Files Challenge Over Plans For Generic NuvaRing

Chicago, IL (PRWEB) January 11, 2014

The birth control resource center at has added new information for those patients using the contraceptive NuvaRing. The maker of the device, Merck, recently challenged another company’s plans to market a generic version in upcoming years*.

DrugNews is a patient resource center offering the latest news, safety alerts, product recalls and litigation updates on popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.

NuvaRing is a small plastic contraceptive insert approved by the FDA for sale in the United States in 2001. Today it is marketed in over 50 countries and used by an estimated 1.5 million people worldwide**.

DrugNews has uncovered health warnings from experts such as the New England Journal of Medicine showing vaginal ring contraceptives like NuvaRing may result in a 6.5 times increased risk of blood clots***.

Now, The resource center has learned NuvaRing maker Merck has filed suit against rival drug company Actavis over allegations that it marketed plans to release a generic version of NuvaRing prior to the expiration of Merck’s patent in 2018*.

According to court records, a number of women have already filed a NuvaRing lawsuit against Merck alleging blood clots from the device, with cases consolidated to a special federal multidistrict litigation court. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. The latest court records show 1,610 cases filed as of December 16****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit

*Bloomberg, 12/24/13;; Merck Sharp & Dohme BV v. Warner Chilcott Co., U.S. District Court, District of Delaware (Wilmington).
**Huffington Post, 12/18/13;
***New England Journal of Medicine, 6/14/12;
****Judicial Panel on Multidistrict Litigation, 12/16/13;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugNews Alerts of Court Records Showing Rise In Mirena IUD Complaints
2. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
3. DrugNews: Federal Court Moves Growing Mirena Lawsuits Forward
4. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
5. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
6. DrugNews: Judge Refuses Bayer Request to Dismiss Mirena Lawsuit
7. DrugNews Adds Latest Court Update on Januvia Lawsuits
8. DrugNews Announces Launch of Topamax Resource Center for Birth Defects
9. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
10. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
11. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: